Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Current availability is shown on this page
This is one of the more translatable research directions to emerge from the GHRP literature
Wegovy is approved specifically for weight management and has been shown to support significant weight loss in clinical studies
To provide better access to these products, PBMs should remove step therapy requirements from both drugs so patients and prescribers have easier access and increase use of SGLT2 therapies, which are generally less expensive but efficacious
November 2025: Boehringer Ingelheim licensed a novel GLP-1 analogue candidate from a research partner to advance its pipeline for type 2 diabetes and obesity indications
US$ 25.19
US$ 28.48
US$ 21.45
US$ 26.85
US$ 28.83
![[Alternate Route] Issue 8 Fall 2022 Mehreen Ahmed:Paperback](https://cdn.shopify.com/s/files/1/0462/1120/3233/files/nkk7zv-front-shortedge-384_afd03c86-eaec-4f5b-9cc4-88f24f797fc0.jpg?v=1718422499)
